ES2099344T3 - FLUPIRTIN AND MORPHINE BASED COMBINATION PREPARATION FOR PAIN TREATMENT AND TO PREVENT ADDICTION TO MORPHINE. - Google Patents

FLUPIRTIN AND MORPHINE BASED COMBINATION PREPARATION FOR PAIN TREATMENT AND TO PREVENT ADDICTION TO MORPHINE.

Info

Publication number
ES2099344T3
ES2099344T3 ES93117472T ES93117472T ES2099344T3 ES 2099344 T3 ES2099344 T3 ES 2099344T3 ES 93117472 T ES93117472 T ES 93117472T ES 93117472 T ES93117472 T ES 93117472T ES 2099344 T3 ES2099344 T3 ES 2099344T3
Authority
ES
Spain
Prior art keywords
morphine
flupirtin
combination preparation
pain treatment
based combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93117472T
Other languages
Spanish (es)
Inventor
Bernd Dr Nickel
Michael Dr Lobisch
Stefan Prof Dr Szelenyi
Jurgen Prof Dr Engel
Peter Dr Emig
Gabriela Dr Pergande
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Application granted granted Critical
Publication of ES2099344T3 publication Critical patent/ES2099344T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The combination of flupirtine and morphine has the property of potent analgesic activity and not generating any morphine-like dependence and tolerance. Novel pharmaceutical compositions containing this combination of active substances are described.
ES93117472T 1992-10-30 1993-10-28 FLUPIRTIN AND MORPHINE BASED COMBINATION PREPARATION FOR PAIN TREATMENT AND TO PREVENT ADDICTION TO MORPHINE. Expired - Lifetime ES2099344T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4236752A DE4236752A1 (en) 1992-10-30 1992-10-30 Combination preparation of flupirtine and morphine for the treatment of pain and for avoiding morphine addiction

Publications (1)

Publication Number Publication Date
ES2099344T3 true ES2099344T3 (en) 1997-05-16

Family

ID=6471783

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93117472T Expired - Lifetime ES2099344T3 (en) 1992-10-30 1993-10-28 FLUPIRTIN AND MORPHINE BASED COMBINATION PREPARATION FOR PAIN TREATMENT AND TO PREVENT ADDICTION TO MORPHINE.

Country Status (11)

Country Link
US (1) US5521178A (en)
EP (1) EP0595311B1 (en)
JP (1) JP3665354B2 (en)
AT (1) ATE147979T1 (en)
BR (1) BR9304431A (en)
CA (1) CA2102072C (en)
DE (2) DE4236752A1 (en)
DK (1) DK0595311T3 (en)
ES (1) ES2099344T3 (en)
GR (1) GR3022995T3 (en)
HU (1) HU219907B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
KR100354702B1 (en) 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 Manufacturing method and sustained release composition of pharmaceutical composition
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19918325A1 (en) 1999-04-22 2000-10-26 Euro Celtique Sa Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
WO2001008682A2 (en) * 1999-08-03 2001-02-08 Awd.Pharma Gmbh & Co. Kg Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats
CA2550023C (en) * 2003-12-16 2011-04-12 Cnsbio Pty Ltd Treatment of neuropathic pain
AU2004298288B2 (en) * 2003-12-16 2011-06-30 Relevare Aust. Pty Ltd Methods and compositions
US7553858B2 (en) * 2003-12-17 2009-06-30 Meda Pharma Gmbh & Co. Kg Combination of flupirtine and tramadol
WO2006024018A2 (en) * 2004-08-24 2006-03-02 Neuromolecular Pharmaceuticals, Inc. Compositions for treating nociceptive pain
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
EP1688141A1 (en) 2005-01-31 2006-08-09 elbion AG The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
PL1874282T3 (en) 2005-04-06 2011-04-29 Adamas Pharmaceuticals Inc Methods and compositions for treatment of cns disorders
US20070042054A1 (en) * 2005-04-20 2007-02-22 Council Of Scientific And Industrial Research Functional aphrodisiac rolled herbal bidis and cigarettes
DK2097469T3 (en) * 2006-11-28 2013-09-16 Purac Biochem Bv STABLE LACTIC PARTICLES
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
CA2751037A1 (en) * 2009-01-30 2010-08-05 Relevare Aust. Pty Ltd. Drug abuse deterrent, methods and compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI855016A (en) * 1985-06-28 1986-12-29 Degussa SYNERGISTIC COMBINATION AV FLUPIRTIN OCH 4-ACETAMIDO-PHENOL.

Also Published As

Publication number Publication date
ATE147979T1 (en) 1997-02-15
HU9303089D0 (en) 1994-01-28
CA2102072A1 (en) 1994-05-01
EP0595311A1 (en) 1994-05-04
HUT66085A (en) 1994-09-28
JP3665354B2 (en) 2005-06-29
HU219907B (en) 2001-09-28
CA2102072C (en) 2005-01-04
BR9304431A (en) 1994-06-07
DE4236752A1 (en) 1994-05-05
US5521178A (en) 1996-05-28
EP0595311B1 (en) 1997-01-22
DK0595311T3 (en) 1997-05-26
GR3022995T3 (en) 1997-07-30
DE59305236D1 (en) 1997-03-06
JPH06211663A (en) 1994-08-02

Similar Documents

Publication Publication Date Title
ES2099344T3 (en) FLUPIRTIN AND MORPHINE BASED COMBINATION PREPARATION FOR PAIN TREATMENT AND TO PREVENT ADDICTION TO MORPHINE.
ATE210983T1 (en) STABILIZED COMBINATION MEDICINAL PRODUCT CONTAINING NALOXONE AND AN OPIATE ANALGESIC
MX9206577A (en) PHARMACEUTICAL COMPOSITION TO INHIBIT THE GROWTH OF TUMOR CELLS
NL194360B (en) Administration device and combination of administration device and housing for containers of the substance to be administered.
LV10270B (en) Novel pharmacological compounds
ATE63813T1 (en) PHARMACEUTICAL COMPOSITIONS OF DIHYDROCODEINES/IBUPROFEN AND PROCESSES.
DE69421689T2 (en) DEVICE FOR IN-LINE ADMINISTRATION OF DRUGS
DE69203990D1 (en) Device for the transdermal administration of medication.
ES2177084T3 (en) USE OF SULFINYL BENZOHIDRILE DERIVATIVES TO TREAT THE SOMNOLENCE OF MEDICINAL ORIGIN.
HUT53521A (en) Process for producing pharmaceutical compositions comprising morphine
ES551441A0 (en) PROCEDURE FOR THE TREATMENT OF PHARMACEUTICAL DOSAGE FORMS
BR9610248A (en) Compound pharmaceutical composition processes for the treatment of pain and for the preparation of a compound and use of the compound
EP0357030A3 (en) Use of thromboxane a2 receptor antagonists for the preparation of a pharmaceutical composition for treating skin injuries
DE60016460D1 (en) USES AND COMPOSITIONS OF NITRATESTERS AS SEDATIVA
DE3765243D1 (en) IBUPROFEN AND CODEIN CONTAINING, STABLE, SOLID MEDICINAL PRODUCTS.
FR2582309B1 (en) NOVEL MORPHINANE AND MORPHINE DERIVATIVES, THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE69006654D1 (en) Medicines containing a zinc complex.
SE8404065D0 (en) NOVEL BIOLOGICALLY ACTIVE COMPOUNDS
EP0227531A3 (en) Pyroglutamic acid esters used as dermal penetration enhancers for drugs
ATE295171T1 (en) ANALGESIC COMPOSITION CONTAINING MOXONIDINE AND AN OPIOID ANALGESIC
DE3788338D1 (en) PRE-TREATMENT ACTIVE INGREDIENT FOR PERCUTANEOUS ADMINISTRATION.
MX164619B (en) COMPOSITION FOR THE TREATMENT OF SKIN INJURIES
ATE106732T1 (en) MEDICATION PREPARATION CONTAINING STIGMASTA-4-EN-3-ONE AND USE THEREOF.
DE69724328D1 (en) Conjugates of an interleukin-2 receptor specific recognizing factor with ribonuclease
PE20020041A1 (en) PHARMACEUTICAL COMBINATION INCLUDING A COMPOUND WITH OPIOID EFFECT AND A PEPTIDIC COMPOUND

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 595311

Country of ref document: ES